Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 3,961 recruiting studies in this area right now.
By phase
- Not applicable2,540
- Phase 2357
- Phase 4303
- Phase 1287
- Phase 3283
- Phase 1/Phase 2132
- Phase 2/Phase 359
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris69
- University of California, San Francisco39
- Johns Hopkins University30
- National Cancer Institute (NCI)28
- Hospices Civils de Lyon27
- Columbia University24
- University of Washington23
- University of Alabama at Birmingham22
- M.D. Anderson Cancer Center21
Where studies are running
- California234
- Maryland142
- Alabama92
- New York73
- Florida72
- Texas62
- Massachusetts55
- Arizona48
- Pennsylvania43
- Illinois41
Recruiting studies3,961 total
- NCT06856174RecruitingPhase 4
Menopause Hormone Therapy for Women with HIV
This trial tests whether hormone therapy can help manage hot flashes and night sweats in women living with HIV who are going through menopause. It's designed to see if this treatment is safe and effective for this group.
Birmingham, AlabamaAges 40–60 - NCT06850350Recruiting
Long COVID and Thinking & Walking
This study looks at how Long COVID affects thinking and movement skills. If you had COVID-19 more than 3 months ago and could walk before you got sick, you may be able to help researchers understand these lasting symptoms.
Chicago, IllinoisAges 18 years+ - NCT06855160RecruitingPhase 3
Chickenpox & MMR Vaccine Study for Healthy Toddlers
This study tests a new chickenpox vaccine combined with a standard MMR vaccine (measles, mumps, rubella) in healthy children aged 12-15 months. The goal is to see how well the vaccines work and how safe they are when given as a shot in the arm.
Tucson, ArizonaAges 1 year–1.3 years - NCT06855498RecruitingPhase 3
Rollover study for patients who took povorcitinib before
This study is for people who have already taken the study drug povorcitinib in a previous trial and found it helpful. It lets you continue receiving the treatment and allows doctors to keep tracking its long-term safety and effects.
Birmingham, AlabamaAges 18 years+ - NCT06854640RecruitingPhase 1
A study of a new medicine for sepsis-related blood clotting problems
This study tests a new medicine called BAY 3389934 to see if it's safe and what dose works best for people with sepsis and blood clotting issues. The goal is to improve blood clotting and help you recover from the infection.
Aurora, ColoradoAges 18–85 - NCT06853184RecruitingPhase 2
Artesunate for CMV in transplant patients
This trial tests a study drug called artesunate as a possible new treatment for CMV (a common virus) in people who have had a kidney, lung, heart, or liver transplant. It is for patients whose CMV infection requires treatment with standard antivirals like ganciclovir or valganciclovir.
Boston, MassachusettsAges 18 years+ - NCT06853301Recruiting
A faster test to find bloodstream infections
This study tests a new machine learning method to quickly identify bacteria in the blood using special sample bottles. If you are getting blood cultures done already, this may help get results faster.
GrenobleAges 18 years+ - NCT06848309Recruiting
Immune response study for influenza or COVID-19
This study looks at how your immune system fights off flu or COVID-19. If you have a current or recent infection, or if you've been vaccinated in the past year, you may be able to join.
St Louis, MissouriAges 18–60 - NCT06855121Recruiting
Norwegian immunotherapy study for multiple myeloma patients
This study collects information from people with multiple myeloma, plasma cell leukemia, or AL-amyloidosis who are about to start a new type of immunotherapy. It helps doctors understand how these treatments work in real life.
ArendalAges 18 years+ - NCT06848387RecruitingPhase 4
Cloxacillin levels during continuous infusion
This trial measures how the body processes cloxacillin when it's given as a continuous infusion for infections. If you're already receiving this treatment, the results may help doctors optimize your dose.
VästeråsAges 18 years+ - NCT06857071Recruiting
Using social networks to find undiagnosed HIV cases
This study tests whether asking people with a new HIV diagnosis to invite their friends and contacts for testing can find more undiagnosed cases and reduce stigma. If you or someone you know was recently diagnosed with HIV in the Msunduzi area, this could help connect more people to care.
Pietermaritzburg, KwaZulu-NatalAges 18 years+ - NCT06853886Recruiting
Genetic study for hepatitis B patients to find new treatment pathways
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
LimogesAges 18 years+ - NCT06850298Recruiting
H5N1 milk detection study
This study looks for the H5N1 virus in the milk of healthy adults. If you are generally healthy and between 18 and 64, you may be able to help by providing milk samples to see if the virus can be detected.
Atlanta, GeorgiaAges 18–64 - NCT06853314Recruiting
PrEP for women with past legal or child welfare involvement
This trial tests a program to help women who have had contact with the criminal legal system or child protective services get and stay on PrEP (a daily pill that prevents HIV). The study also looks at how to support women who have experienced intimate partner violence or risky drinking.
New York, New YorkAges 18 years+ - NCT05821478RecruitingPhase 3
Antibiotics plan for hidradenitis stage 2 flares
This Phase 3 study tests whether an adapted antibiotic treatment works better than the standard approach to control hidradenitis suppurativa (HS) symptoms and flares. It may help people with stage 2 HS reduce active inflammation and flare-ups.
MarseilleAges 18–59 - NCT06843018RecruitingPhase 2
Spray vs lozenge for sore throat from infection
This trial tests a new spray with anesthetic for sore throat caused by infections like pharyngitis. It compares the spray to a lozenge (Septolete Total) to see which works better and is safer.
Engel'sAges 18–75 - NCT06843226Recruiting
Dengue vaccine study for children and teens
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
Banjarmasin, South KalimantanAges 6–12 - NCT06842173RecruitingPhase 1/Phase 2
Safety testing of new bird flu vaccine (H5N8) in adults
This trial tests a new bird flu (H5N8) vaccine for adults aged 18 and older. It looks at how safe the vaccine is and how well it triggers an immune response. The vaccine is given as a shot and includes an adjuvant to boost protection.
Belo Horizonte, Minas GeraisAges 18 years+ - NCT06577558RecruitingPhase 2
SR1375 for severe pneumonia not improving on antibiotics
This trial tests a new drug called SR1375 for adults with severe community-acquired pneumonia (a lung infection) who are not improving with standard antibiotics. It may help reduce inflammation and speed up recovery.
Fuyang, AnhuiAges 18–85 - NCT06841003RecruitingPhase 3
Antibiotic rinse during appendix surgery to prevent abscess
This trial tests whether rinsing the belly with antibiotics during appendix removal surgery can lower the chance of a pocket of infection (abscess) forming afterward. It may help people with a more severe type of appendicitis called complicated appendicitis.
Heerlen, LimburgAges 8 years+ - NCT06845332Recruiting
Best treatment choices for newborns with suspected early infection
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
AlkmaarAges Up to 3 days - NCT06835842Recruiting
Rib mobilization for pneumonia patients on a ventilator
This study tests whether a gentle rib movement technique (called rib mobilization) can help people with pneumonia who are on a breathing machine get ready to breathe on their own. It aims to see if this therapy makes it easier to wean off the ventilator.
CairoAges 40–50 - NCT06841237Recruiting
Ointment for diabetic foot ulcer healing
This study tests whether a traditional Chinese ointment (Xiang Lei) can help heal diabetic foot ulcers. It is for people with diabetes who have a wound that is already starting to heal (granulation phase) and whose blood sugar is well-controlled.
Beijing, Beijing MunicipalityAges 18–80 - NCT06841913RecruitingPhase 4
Woodsmoke, flu, and your nasal immune response
This study tests how breathing woodsmoke affects your nose's ability to fight off the flu virus. You will be exposed to woodsmoke and then given a live flu vaccine to see how your immune system responds.
Chapel Hill, North CarolinaAges 18–49
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 3,961 recruiting infectious disease studies from the U.S. registry right now, out of 6,600 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.